Radiation gastritis can be treated with hormones, but the specific efficacy varies from person to person, and the use of medication must be carried out under the guidance of a doctor. Commonly used therapeutic drugs for radiation gastritis include adrenocorticotropic hormones such as prednisone, hydrocortisone and methylprednisolone, which can relieve gastric mucous membrane damage and reduced gastric acid secretion of patients with this disease through anti-inflammatory, immunosuppressive and other pharmacological effects. Therefore, radioactive gastritis can choose hormone treatment. However, it should be noted that hormones are not essential for the treatment of radiation gastritis, but there are other drugs such as gastric mucosal protective agents (e.g., aluminum thioglycollate), aminosalicylic acid preparations (e.g., salazosulfapyridine), and probiotics (e.g., Bifidobacterium trichotomosum) for selection. The efficacy of hormone therapy may vary depending on the patient’s physical condition, compliance, and the severity of the disease. It should also be noted that adrenocorticotropic hormone is contraindicated for those who are allergic to this type of drug, and should be used with caution for those who have hypertension, diabetes, glaucoma, etc. Adverse effects such as infections, peptic ulcers, muscle weakness, etc., may occur in the process of using the drug. Therefore, the diagnosis of radiation gastritis, must be under the guidance of the doctor for the choice of drugs and other therapeutic measures and adjustments, do not blindly use drugs or increase or decrease the dosage of drugs, so as not to cause adverse consequences.